Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Natera Research Grant Focused on Innovative Uses of Personalized Molecular Residual Disease Testing in Gynecologic Cancers

    Natera Research Grant Focused on Innovative Uses of Personalized Molecular Residual Disease Testing in Gynecologic Cancers supports investigators studying MRD-informed care to improve gynecologic cancer management.

    Browse similar grants
    Cancer Research Grants 2026Foundation Grants for Biomedical Research
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Foundation for Women's Cancer

    Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposal)

    Funding Amounts: $50,000 for one year

    Summary: Supports innovative personalized molecular residual disease testing research to improve gynecologic cancer management.

    Key Information: Research must take place at a U.S. institution; full professors are ineligible.


    Description

    Offered through the Foundation for Women’s Cancer (FWC), this Natera-supported grant funds research incorporating personalized molecular residual disease (MRD) testing into the management of ovarian, endometrial, cervical, and other gynecologic cancers. Priority goes to prospective, interventional designs examining the value of MRD-informed care. Studies focused on feasibility, detectability, or general prognostic value receive less priority.

    Research interests include decision-impact studies that optimize treatment strategies; circulating tumor DNA (ctDNA) monitoring to guide treatment escalation, de-escalation, or switching; and ctDNA as a surrogate endpoint for treatment efficacy or survival. The program also supports MRD-guided interventions to reduce overtreatment and toxicity, including financial toxicity, and surveillance studies using ctDNA dynamics to guide imaging or treatment escalation.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.